Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human... see more

TSXV:CZO - Post Discussion

Ceapro Inc > Time to put on the Big-Boy pants.
View:
Post by captwade on Aug 26, 2020 1:11pm

Time to put on the Big-Boy pants.

When a company is trying to stimulate the share price they should at least take advantage of the more obvious ways to do so.

These guys missed an obvious opportunity to revise the sales projections for this year.  Did they not predict 10% sales growth?  With first 6 months up 43% and most recent quarter up 53% the year would finish up 21% even if Q3 and Q4 were totally flat, something which seems highly unlikely at this point. 

It was good to see the TMX site revised to reflect the current financials by showing a P/E of 30 and as Fossi mentioned recently we are trending towards a year end P/E of 13 or so.

There is little not to like with Ceapro currently and those of us who hold shares are probably in for a nice ride.
Comment by EbbFlow88 on Aug 26, 2020 2:19pm
Not many sellers here and there's a large spread. 1,200 shares today so far. Very encouraging. Most here seem to think similarly. Can't wait to see what this PGX deal will look like.
Comment by Ciao on Aug 26, 2020 2:20pm
Great point.  They could have put a "!" on those great results noted in Q2 (and for H2) and revised upward revenue projections for the year.  Not even promotional if they said we will meet or exceed our 10% rev increase from 2019, perhaps be bold enough to say rev increase of 20 - 30% and still leave room for a surprise. Guess they are not that promotional at all.
Comment by Minty_33 on Aug 26, 2020 8:10pm
Ciao said: "Guess they are not that promotional at all" That would be considered by many to be an understatement and probably the reason for the lack of consistent volume. The story is great but it's not out there. What ever happened to the functional drink deal and the two U.S pharma companies / monoclonal antibody drying? This was said to be and I quote "a longer term ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities